The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The U.S. has had 935 confirmed cases of measles so far this year, according to the latest data from the Centers for Disease Control and Prevention. Cases have…
Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and…
Headline
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections…